Elena Garralda

Elena Garralda MD PhD, is a researcher and clinical investigator. Currently she is the Director of the Research Unit for Molecular Cancer Therapy (UITM) – “CaixaResearch”, the Codirector of the Clinical research Program at VHIO, and the Director of the Phase I Unit at NEXT Oncology, both in Barcelona, Spain. In this capacity, she oversees one of Europe’s premier centers for Phase I and complex early-phase clinical trials, focusing on targeted therapies and innovative immunotherapies. Beyond her institutional leadership, Dr. Garralda holds several influential positions within the international oncology community. She chairs the European Organization for Research and Treatment of Cancer (EORTC) RECIST Task Force, where she spearheads the development of global standards for assessing tumor response. Reflecting her standing in the field, she is Chair for the 38th EORTC–NCI–AACR (ENA 2026) Symposium, a flagship forum for molecular targets and cancer therapeutics. Dr Garralda is PI and Proje